Table 2

Number of subjects with satisfactory relief of symptoms for 0, 1, 2, and 3 weeks in the two treatment periods.

Number of subjects with satisfactory relief of symptoms for 0, 1, 2, and 3 weeks in the placebo period

Total no. of subjects

0 week

1 week

2 weeks

3 weeks

Number of subjects

0 week

4

4

1

2

11

with satisfactory relief

1 week

1

0

0

2

3

of symptoms for 0, 1, 2, and 3 weeks

2 weeks

0

0

1

0

1

in the LpMF1298 period

3 weeks

0

0

0

1

1

Total no. of subjects

5

4

2

5

16

The difference in favor of placebo was statistically significant (P = 0.012).

Ligaarden et al. BMC Gastroenterology 2010 10:16   doi:10.1186/1471-230X-10-16